Furthermore, ITGAL is associated with poor prognosis in ovarian cancer (Wu A. et al., 2020), while it also suggests better prognosis and inhibits tumor proliferation in NSCLC (Wang et al., 2023). Here, ITGAL is linked to neoplasm.